PERSPECTA

News from every angle

← Back to headlines

Jim Cramer Advises Speculation on ImmunityBio Stock

Jim Cramer recommended ImmunityBio as a speculative investment to a caller, indicating potential for the stock.

19 Jun, 13:35 — 19 Jun, 13:35
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual59d ago

Jim Cramer Says “Let ImmunityBio Be Your Speculation” to a Caller

Read full article →

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

35m ago

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

40m ago

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

42m ago

KBR Secures $60 Million NATO Contract for Missile Defense System

52m ago